person
as of 2026-07-01Debasish Hota, MD, DM
DEBASISH HOTA, DM
at a glance
Roles: Study Chair, Study Director, Author
KOL signal score 2
1 publications · 0 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Professor & Head
Roles
Study Chair, Study Director, Author
KOL signal
2
Publications
1 (0 high-value)
Trial investigator
no
Publishes on
1 drugs
Trials led
2
Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
NCT03304457Phase 4Completed
Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia
NCT03075657Phase 4Completed
Publications & congress
1
Lumateperone as an alternative to clozapine in treatment-resistant schizophrenia: Insights from a quantitative systems pharmacology model.
The Journal of pharmacology and experimental therapeutics · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here